2012
DOI: 10.1016/j.pain.2011.08.015
|View full text |Cite
|
Sign up to set email alerts
|

Microneurographic identification of spontaneous activity in C-nociceptors in neuropathic pain states in humans and rats

Abstract: C-nociceptors do not normally fire action potentials unless challenged by adequate noxious stimuli. However, in pathological states nociceptors may become hyperexcitable and may generate spontaneous ectopic discharges. The aim of this study was to compare rat neuropathic pain models and to assess their suitability to model the spontaneous C-nociceptor activity found in neuropathic pain patients. Studies were performed in normal rats (n=40), healthy human subjects (n=15), peripheral neuropathic pain patients (n… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
151
1

Year Published

2013
2013
2023
2023

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 182 publications
(154 citation statements)
references
References 41 publications
2
151
1
Order By: Relevance
“…The same result was found in a different study in patients with small-fiber neuropathy (Fig. 4) (Serra et al, 2012).…”
Section: Diabetic Neuropathysupporting
confidence: 88%
“…The same result was found in a different study in patients with small-fiber neuropathy (Fig. 4) (Serra et al, 2012).…”
Section: Diabetic Neuropathysupporting
confidence: 88%
“…Therefore, the 200 Hz with 5 ms intervals in the present study might potentially be associated with less efficiency of afferent input to the spinal neurons compared with the lower frequencies. Compared with A-fiber nociceptors, C-nociceptors are not capable of following the high frequency electrical stimulation (100 Hz and 200 Hz) used in the present study leading to direct conduction failure (Raymond et al, 1990;Weidner et al, 1999;Serra et al, 2012).…”
Section: Conditioning Stimulation Frequencymentioning
confidence: 74%
“…A prominent feature of PDN is neuropathic pain, which is typically characterized in its early phase by hyperalgesia, allodynia, spontaneous pain (Serra et al, 2012;Clark and Lee, 1995). It is well known that the anti-epilepsy drug GBP has a wide use in the treatment of chronic pain conditions, particularly neuropathic pain (Rosenberg et al, 1997;Lin et al, 2005;Jones and Sorkin, 1998).…”
Section: Introductionmentioning
confidence: 99%